Inhalation of common indoor fi lamentous fungi has been associated with the induction or exacerbation of allergic respiratory disease. The understanding of fungal inhalation and allergic sensitization has signifi cantly advanced with the use of small animal models, especially mouse models. Numerous studies have employed different animal exposure and sensitization techniques, each with inherent advantages and disadvantages that are addressed in this review. In addition, most studies involve exposure of animals to fungal spores or spore extracts while neglecting the infl uence of hyphal or subcellular fragment exposures. Recent literature examining the potential for hyphae and fungal fragments to induce or exacerbate allergy is discussed. Innate immune recognition of fungal elements and their contribution to lung allergic infl ammation in animal models are also reviewed. Though physical properties of fungi play an important role following exposure, host immune development is also critical in airway infl ammation and allergy. We discuss the importance of environmental factors that infl uence early immune development and subsequent susceptibility to allergy. Murine studies that examine the role of intestinal microfl ora and prenatal or early life environmental factors that promote allergic sensitization are also evaluated. Future studies will require animal models that accurately refl ect natural fungal exposures and identify environmental factors that infl uence immune development and thus promote respiratory fungal allergy and disease.
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Keywords mouse models, fungal allergy, spores, hyphae, inhalation wide variety of reproductive structures that include asexual conidia, sexual spores, fragmented hyphae, and subcellular particulates [2] . In the environment, the mycoaerosol fraction contains various mycotoxins and allergens that represent a large burden to public health [1, 3] .
Inhalation of fungal spores, often considered the traditional route of exposure, has been associated with the induction or exacerbation of respiratory diseases such as asthma, allergic rhinitis, sinusitis, or hypersensitivity pneumonitis [4] [5] [6] [7] . Spores derived from Alternaria, Aspergillus, Penicillium, and Cladosporium species are environmentally abundant, and predominantly correlated with exacerbations of allergic rhinitis and asthma [8] [9] [10] [11] [12] [13] . With the exception of several preliminary studies, the contribution of other non-dimorphic fi lamentous fungi and
Introduction
Non-dimorphic fi lamentous fungi are ubiquitous saprophytic, symbiotic, or parasitic heterotrophs that acquire extracellular nutrients for metabolic and physiological processes [1] . In the absence of critical nutrients and other environmental factors, fungi differentiate to produce a fungal fragments has been widely ignored [2, [14] [15] [16] [17] . Some of these fragments release allergens and are reported to represent up to 56% of the total fungal particulate load [2] . Fungal fragmentation is particularly important in water damaged indoor environments where concentrations of fragments can be signifi cantly higher than conidia [14, 16] . Another important consideration is the role of fungal toxicity in respiratory disease. Although fungal allergen and mycotoxin exposure may pose a threat to immunocompetent individuals, immunocompromised patients (undergoing chemotherapy or infected with human immunodefi ciency virus) are at greater risk. Immunocompromised patients exhibit decreased clearance of fungal spores from the lungs that potentiates widespread systemic fungal infection that may ultimately prove fatal [18] .
Numerous studies have detailed the basic immune responses to fungal deposition in the lung and other peripheral tissues. In the lungs, alveolar macrophages are among the fi rst cells to encounter inhaled fungi [19] , and generally promote tolerance over immune activation [20] . Maintaining tolerance is an important function of surveillance in tissues such as the lungs that regularly encounter substantial amounts of innocuous antigens and microbes. Although large numbers of inhaled fungal spores are removed from the lungs prior to germination [21] , conidia that escape phagocytosis may begin to germinate, and thus release fungal factors that initiate lung infl ammation [22, 23] . The early innate response to fungal deposition in the respiratory tract ultimately shapes the adaptive immune response. Lung dendritic cells (DCs) take up and transport fungal particles to bronchial lymph nodes where antigens are presented to naive T-cells. DCs also help to determine the level, direction, and priming of antigen-specifi c T-helper cells via co-stimulatory signals [24] [25] [26] . Dormant or nonviable A. fumigatus conidia uptake is associated with IFN-γ production and Th1 responses, while hyphae or swollen (germinating) conidia induce IL-4 production and eosinophil recruitment, a hallmark of allergic infl ammation and Th2 responses [27] . Therefore, successful germination is likely to contribute to the development of fungal allergy, although the precise mechanism remains unclear and requires further investigation.
Although specifi c fungal structures and secreted factors play an important role in allergic sensitization, environmental factors are also critical. Results from epidemiological studies suggest that factors that infl uence early life immune development are critical for subsequent development of tolerance or allergic sensitization [28, 29] . Early infections and non-invasive microbial exposures are generally protective against allergic sensitization. In contrast, decreased microbial exposure as a result of antibiotic use, dietary modifi cation, or birth by caesarian section results in increased incidence of allergy [30] . Although the association is widely acknowledged, the mechanism by which early life microbial exposures or infections confer protection from fungal allergy remains poorly understood.
Studies of fungal inhalation, allergy, and infection have benefi tted greatly from the use of small animal models. Mice, rats, rabbits, and guinea pigs are common species that are used to evaluate fungal pathology and lung immunity [1, 31, 32] . In addition to variability encountered between animal species, the route and method of lung exposure may also differ between individual studies. Some groups provide fungal exposure via inhalation of fungal spores or extracts in suspension through the nares, while others use involuntary aspiration or intratracheal instillation. Studies of fungal allergy involve chronic lung exposure to spores, extracts, or systemic sensitization to fungal allergens prior to respiratory challenge. Each type of animal species and method employed in these studies possess different strengths and weaknesses with regard to modeling fungal exposure and allergic sensitization in humans. The purpose of this review is to provide a summary and evaluation of animal studies of fungal inhalation and allergy, focusing on murine models of airway allergy to non-dimorphic fi lamentous fungi commonly found in indoor environments, the implications of the fi ndings, as well as the potential of these models to answer future questions in the fi eld of allergy and fungal disease.
Animal models of fungal inhalation
Animal models are used to examine immune mechanisms associated with fungal clearance, infection, tolerance, and allergy. Several different methods of exposure have been employed in non-sensitized animals including rats, mice, rabbits, and guinea pigs (Table 1) [1] . Aspergillus, Penicillium, and Stachybotrys are examples of fungal genera commonly used in exposure models, especially as these fungi are associated with indoor fungal contamination arising from water-damaged building materials [33, 34] . The most common methods used to expose mice to fungi include involuntary aspiration and intranasal instillation.
Aspiration
Involuntary (pharyngeal) aspiration involves the delivery of either an aliquot of fungal spores or an extract suspended in saline, onto the vocal folds or base of the tongue of an anesthetized animal [35] [36] [37] . Nasal breathing is then blocked with a gloved fi nger tip, and mice are allowed to inhale the suspension. Using this method, the fungal suspension is delivered throughout the entire lung. In contrast, intranasal instillation delivers fungal suspensions into the lung through the nares of anesthetized animals [35, 38] . Both involuntary aspiration and intranasal instillation allow for a homogenous suspension of fungi to be administered to the animal. However, these methods are not refl ective of natural fungal exposures (inhalation of dry aerosols) since extracellular and intracellular antigens may be directly released into the suspension. This may not only alter the concentration of soluble antigens, but may also alter the physical and metabolic properties of fungal particles.
Aerosol chambers
Aerosol chambers are used to monitor the response of an animal to prolonged fungal exposures [35, 39, 40] . Experimental aerosols can be generated by dry particle aerosolization from growing fungal cultures or by nebulization using a suspension of fungal particles. During dry particle aerosolization, air fl ows across growing fungal cultures and spores, hyphae, and subcellular fragments are suspended and the aerosol is directed into an air fl ow controlled exposure chamber [39] . For nebulization, fungal particles are collected into a physiological buffer and then aerosolized into the chamber using a nebulizer. Animals are exposed by either a whole body or nose-only exposure system. Whole body exposures with fungal aerosols introduce the possibility that fungal antigens may be ingested by the animal during grooming [41] . Although chamber exposures allow for accurate monitoring and maintenance of airborne particle concentrations inside the chamber, the actual amount and distribution of fungal particles deposited inside the respiratory tract of the animals cannot be controlled. These attributes depend on the breathing patterns of the animal and vary due to aggregate formation, electrostatic interactions with the chamber wall, and the degree of mucociliary clearance of fungal particles from mucosal surfaces within the nares and trachea of the animal [1, 39] .
Aspergillus fumigatus. A. fumigatus is the most widely studied fungal species used in animal models. A. fumigatus is a ubiquitous, saprophytic, thermotolerant fungus that grows in moist environments, and may colonize the respiratory tract or inhabit the gastrointestinal tract of immunocompromised individuals [41] [42] [43] . It is commonly associated with invasive aspergillosis or allergic bronchopulmonary aspergillosis (ABPA) in immunocompromised patients, and is associated with allergic sensitization and exacerbations of asthma in immunocompetent individuals [5, 44] . Rabbits exposed to a single dose of A. fumigatus spores using an exposure chamber developed an infl ammatory response characterized by the recruitment of macrophages, lymphocytes, and a mild thickening of the alveolar walls [41] . Elevated levels of macrophages and lymphocytes were shown to persist for up to 8 days, and were visible in granulomas. Macrophages phagocytose approximately 19% of A. fumigatus spores within 4 h of exposure [21] . However, spores surviving beyond this interval may potentially germinate in the lungs. This ability to persist and germinate within macrophages is a unique characteristic of A. fumigatus [21] . A. fumigatus produces virulence factors that contain cellular adhesive properties [45] and inhibit epithelial cilia beat frequency [46] , macrophage phagocytosis [46] [47] [48] , and production of [35, [39] [40] [41] 53, 56] exposure. Albumin, total protein, and LDH levels were not signifi cantly increased in the lungs compared to control animals. Therefore, P. spinulosum can also induce infl ammation in the lungs of mice, although the magnitude is decreased compared to infl ammation induced by A. versicolor [54, 55] .
Stachybotrys chartarum. S. chartarum is another fungus associated with moisture damaged buildings [34] . Aspirated S. chartarum extracts were capable of inducing an acute systemic infl ammatory response in mice as well as increasing total IgE levels [37] . A single dose of this extract was capable of inducing an infl ux of neutrophils and lymphocytes to the lung. Furthermore, mice exposed to S. chartarum extracts four times over a four week period also showed increased macrophage, neutrophil, lymphocyte, and eosinophil levels in the lung, as well as increased total protein and LDH levels in the BALF [37] . IL-5, a cytokine critical for eosinophil production and activation, was also increased. The use of extracts or fragments instead of whole spores in exposure studies of S. chartarum may have increased relevance, since the large spore size makes inhalation of intact airborne spores less likely, and inhalation of smaller fungal fragments more likely [56, 57] . Another study examined the response of mice exposed to spores of S. chartarum twice a week over a 3 week time period via intranasal instillation [58] . In this study, two strains of S. chartarum were used, a non-toxic strain producing low levels of mycotoxins and a highly toxic strain. The toxic strain produced various mycotoxins such as satratoxin G, satratoxin H, stachybotrylactone, and stachybotrylactam. The results of this study showed that spores of the toxic strain induced infi ltration of neutrophils, macrophages, and lymphocytes to the bronchioles and alveoli of the lung. Exposures to non-toxic spores yielded results similar to those in the control group. Thus, mycotoxin producing strains of S. chartarum can induce pulmonary hemorrhage as well as severe infl ammation and destruction of lung tissue, demonstrating the need for studies to characterize the effects of long term exposure to other toxin-producing fungi.
Factors affecting fungal exposure
In addition to fungal species considerations, the strain of animals used in exposure studies, as well as the frequency and dose of exposure are also important factors. It is well known that genetic factors contribute to the ability of individuals to respond to potential pathogens, including fungi. Genetic variation is also observable in animal fungal exposure studies. Of three congenic mouse strains (BALB/c, C3H/HeJ, C56BL/6), BALB/c mice exhibited reactive oxygen species [46, 49] . These factors may promote spore germination and further colonization within the respiratory tract and bronchioles. Furthermore, germinated A. fumigatus spores express greater amounts of allergen compared to ungerminated spores [50, 51] . These studies lead to the hypothesis that viable fungal elements, after germination in the human respiratory tract, may release greater concentrations of allergen than previously thought. It is unknown if the unique secretory products released from this fungus are potentially interacting with cytokines or chemokines to induce or hinder this observed effect, or if some other fungal-specifi c mechanism is responsible.
Aspergillus terreus. An early line of respiratory defense against fungal exposures involves the recruitment of alveolar macrophages. Intratracheal instillation studies using A. terreus, a ubiquitous thermotolerant human pathogen, showed that macrophages phagocytose 42% of spores immediately following instillation. Within 30 min, 78% of intratracheally instilled A. terreus spores were removed [52] . Using a single dose, granulomas were observed in some animals within 7 days of treatment. Despite the presence of lesions, no serum antibody response to A. terreus was detected [52] . In another study, using an exposure chamber, rabbits also failed to produce an anti-fungal antibody response to A. terreus [39] .
Aspergillus versicolor. Aerosols of the non-thermotolerant fungus A. versicolor; a common indoor contaminant and aeroallergen, provoke respiratory irritation in mice after aerosol chamber exposure [53] . In another study, a dosedependent infl ammatory response was observed following involuntary aspiration [54] . Exposure of mice to single doses ranging from 1 × 10 5 to 1 × 10 8 spores resulted in increased neutrophils in bronchoalveolar lavage fl uid (BALF) within 24 h. Furthermore, proinfl ammatory cytokines such as TNFα and IL-6 were detected in the sera within 6 h of exposure and remained elevated for 3 days at the highest dose. Albumin, total protein, and lactate dehydrogenase, indicating vascular leakage and cytotoxicity, were signifi cantly increased and remained elevated for 7 days. Within 3 days of exposure, alveolar macrophages and neutrophils were the primary cells in the lung [54] .
Penicillium spinulosum. P. spinulosum is commonly associated with water damaged buildings. Studies have demonstrated increases in TNFα and IL-6 levels within 6 h of exposure in the sera of mice aspirated with 5 × 10 6 spores [55] . Lung infl ammation was characterized by elevated levels of neutrophils paired with a decrease in alveolar macrophages in the BALF within 24 h post sensitization may be achieved solely by airway challenge of ovalbumin, but this method is less effi cient and may require the presence of lipopolysaccharide (LPS) in the ova preparation [60] . The most common mouse strain used in allergic sensitization models is Balb/c, due to immune responses which generally favor Th2 over Th1 [61, 62] . However, C57BL/6 and other strains have also been used.
Fungal extract sensitization
Studies that examine the potential of fungi to induce or exacerbate respiratory allergic responses have adapted the ova model to study fungal allergy. A. fumigatus, the etiologic agent of ABPA, is the most widely studied species in evaluating fungal sensitization [44] . In many of these studies, fungal extracts are instilled into the nares or trachea of previously sensitized mice (Table 2) . Sensitization is induced by repeated intranasal exposures or injection of extracts with or without adjuvant [63, 64] . In sensitized mice, fungal extracts induce eosinophilic airway infl ammation, goblet cell hyperplasia, and mucous accumulation in the lungs [44] . Severe allergic infl ammation in response to fungal extracts is characterized by pulmonary epithelial cell metaplasia, collagen deposition, and fi brotic lesion formation. Studies using this approach have demonstrated the requirement for CD4 T-cells and the Th2 cytokines IL-4 and IL-5, but not B-cells or IgE production, in the induction and maintenance of allergic airway responses to crude extracts of A. fumigatus [63, [65] [66] [67] . The central component of the complement pathway, C3, and the receptor for the complement factor C3a (C3aR), are also important for Th2 effector functions in this model, as defi cient mice displayed decreased airway hyperresponsiveness, eosinophilia, and IL-4 producing cells [68, 69] . These studies demonstrate that Th2-effector cells and cytokines are important for allergic airway responses to crude extracts of A. fumigatus, with the complement pathway also a contributing factor. Although repeated fungal exposures of sensitized mice are generally administered by intransal inoculation due to ease and consistency of delivery, allergic airway responses may be induced by other methods of exposure. For instance, sensitized mice exposed to an aerosolized mycelial extract of S. chartarum in an exposure chamber model exhibited airway infl ammation, increased IgE production, and airway hyperresponsiveness when compared to mice exposed to ovalbumin (Table 2) [56].
Whole spore exposure/sensitization
Airway responses to intact fungal spores have also been examined in fungal-sensitized mice (Table 2) . Hogaboam et al. the strongest infl ammatory response to S. chartarum [59] . Furthermore, exposed animals may be overwhelmed by large doses, potentially leading to nonspecifi c lung immune responses. Human exposure to fungal concentrations exceeding 1 × 10 6 spores m -3 are possible in environments that are known to harbor large quantities of fungi (i.e., moist/water damaged buildings and agricultural industries) [1], though it is rare that humans routinely encounter doses commensurate with those used in many animal studies. Therefore, models noting that the degree of infl ammation and immune responses is dose-dependent may have limited biological relevance to natural human fungal exposure.
These studies indicate that characteristics of respiratory infl ammation in response to fungal exposure are species-specifi c, and may be infl uenced by physical characteristics such as optimal growth temperature and by mycotoxin production. In the future, animal exposure models that will determine the contribution of these factors to acute and chronic health effects of fungal inhalation need to be developed. In addition, other studies will need to examine dry aerosol fungal particles and the relevance of fungal fragments on the severity of disease.
Models of fungal allergy
Allergies affect up to 30% of the population in industrialized nations, with up to 12% suffering from asthma [5, 6] . Many factors have been attributed to the rapid increases in the incidence of allergy over the last 20 years including decreased exposure to environmental microbes during prenatal and postnatal immune development. Reduced exposure may lead to a loss of immune tolerance mechanisms resulting in allergy or autoimmunity in susceptible individuals [29] . Although genes play an important role in susceptibility, the triggers for development of sensitization are largely environmental. Aeroallergens may be characterized as seasonal outdoor allergens and include pollen produced by trees, herbaceous shrubs and grasses, or as perennial indoor allergens including animal dander or cockroach allergens [5] . However, fungi are found in both indoor and outdoor environments. Respiratory symptoms are present in up to 30% of atopic individuals who are sensitized and produce specifi c IgE to fungal allergens [5] .
The most common experimental allergen used in animal models of allergic asthma is chicken ovalbumin (ova). In a typical protocol, mice are sensitized by i.p. injection with ova and the adjuvant, aluminum hydroxide (Alum) [60] . In the weeks following the initial sensitization, mice are boosted with an intranasal instillation or pharyngeal aspiration of ova. Finally, a challenge of ova is given, and animals are sacrifi ced at least 24 hours later. Blood is collected for measurement of IgG and IgE antibody titers. Alternatively, In addition to PAR-mediated effects, other microbial pattern receptors play a role in early immune recognition of fungi. Among these are toll-like receptors (TLRs) 2 and 4 and the C-type lectin receptor Dectin-1. TLR2 and TLR4 recognize fungal mannan and β-glucan, respectively. These TLRs are important for recognition of A. fumigatus by murine macrophages, and concomitantly enhance macrophage activation and cytokine production [93] [94] [95] . Dectin-1 also acts as a receptor for β-glucan, a ubiquitous polysaccharide component of fungal spores and hyphae [96] . Dectin-1 is highly expressed by cells of the myeloid lineage [97] . Dectin-1-expressing macrophages and neutrophils are activated by β-glucan on the surface of germinating conidia to produce proinfl ammatory cytokines [22, 98] . Mice defi cient in Dectin-1 lack the ability for in vivo cytokine production in responses to and in subsequent removal of fungi [99, 100] . Although activation of these pattern receptors by fungal ligands and subsequent activation of innate immune cells has been reported, much less is known about the infl uence of these signals on the development of adaptive allergic airway responses. In contrast to the Th2 promoting protease activation, the TLR signaling molecule MyD88 enhanced CD4 + T cell priming and Th1 cytokine production during respiratory infection with A. fumigatus [101] . The role of Dectin-1 in CD4 + T cell priming and differentiation in response to fungal infection remains unclear. However, recent evidence suggests a role in activation of Th17 cells, a T-helper cell lineage distinctly separate from Th1/Th2 phenotypes [102] . IL-17 produced by Th17 cells contributes to lung infl ammation in a mouse model of pulmonary aspergillosis by stimulation of neutrophil-mediated killing of conidia [103] . The role of IL-17 in fungal allergic sensitization is not clear, although ova sensitized mice lacking IL-17 activity and Th2-attracting chemokine CCL11 (Eotaxin) [77] exhibited decreased acute, but not chronic airway allergy in response to A. fumigatus challenge. Therefore, the expression of chemotactic factors and receptors expressed by Th2-cells, neutrophils, eosinophils, mast cells, and monocytes/macrophages may infl uence the induction and maintenance of airway hyperreactivity and lung allergic responses to challenge with A. fumigatus spores in sensitized mice.
Spores of Alternaria alternata, Cladosporium herbarum, and Penicillium chrysogenum are other aeroallergen sources [5] that induce allergic infl ammation in the lungs of mice (Table 2) [78, 79] . In contrast to A. fumigatus studies that sensitized mice by i.p. injections of spore extracts prior to whole spore challenge, whole fungal spores of A. alternata or C. herbarum emulsifi ed in Alum were used [78] . Sensitized mice exhibited airway infl ammation, hyperreactivity, and eosinophilia after intranasal challenge with conidia. In a subsequent study, unsensitized mice treated with spores required chronic exposure to develop airway infl ammation comparable to sensitized mice [80] . Furthermore, repeated exposures of mice to non-viable conidia of P. chrysogenum induced Th1 responses compared to Th2-type responses to viable conidia [79] . The effect of fungal inhalation on allergic sensitization to non-fungal allergens has also been examined. In a recent study, an extract of A. alternata demonstrated potent Th2-adjuvant effects to the antigen ovalbumin in the airways of exposed mice [81] . The Th2 adjuvant activity of A. alternata was signifi cantly more potent than that of A. versicolor, suggesting that the effect on allergic sensitization by fungal exposure is species-specifi c.
Induction of fungal allergy: tolerance vs. sensitization

Fungal-specifi c host recognition
Another critical area of investigation has focused on the physical characteristics of fungi and fungal proteins that promote allergy and asthma in susceptible individuals. Many fungal and non-fungal allergens exhibit protease activity. Allergens derived from Aspergillus [82] and Penicillium [83] species are among the fungal protease allergens isolated [84, 85] . Extracts of A. alternata contain proteases that stimulate infl ammatory cytokine production in epithelial cells in vitro [86] . Sensitization with protease extracts of P. chrysogenum signifi cantly increased allergic airway infl ammation in mice exposed to viable conidia [83] . The commonality of protease activity in allergens suggests that proteases may function as an adjuvant for the induction of sensitization to other studies have demonstrated decreased development of asthma in children raised on farms compared to similar children raised in non-agricultural households [29] . The timing of exposures appears critical in protection from allergy; exposures during the fi rst year of life and even prenatal exposures may play a role [108] . Another interpretation of the hygiene hypothesis proposes that changes in gut microfl ora due to diet, antibiotic use, and birth by caesarean section lead to an increase in the incidence of airway allergic disease [30] . An absent intestinal microbiota alters immune development, as completely germ-free mice exhibit poorly formed secondary lymphoid tissue and antibody responses [109] . In addition, immunocompetent mice exposed to the antibiotic cefoperazone with subsequent oral inoculation of Candida albicans exhibited altered intestinal microfl ora and increased allergic airway responses to intranasal inoculation of A. fumigatus compared to control mice that did not receive antibiotic treatment [110, 111] . Therefore, these results suggest that altered intestinal microfl ora may lead to fungal airway allergy.
Respiratory tolerance can be induced by dendritic cells through IL-10-mediated development of CD4 + regulatory T cells (T reg ) [24] . In the lungs and draining lymph nodes of mice exposed to an intranasal suspension of A. fumigatus conidia, T reg cells acted early to suppress neutrophilic infl ammation and also limited subsequent Th2 responses [112] . T reg suppression of airway allergy was dependent on the activity of indoleamine 2,3 dioxygenase (IDO). IDO is a tryptophan catabolizing enzyme highly expressed by DCs that, in addition to IL-10, mediates T-cell tolerance by induction of T reg cell development [113] . The two major subsets of regulatory T-cells are identifi ed as natural and inducible T reg cells. Natural T reg cells develop in the thymus and are present before pathogen exposure, and inducible T reg cells are generated in the periphery and acquire regulatory function during immune responses [114] . Large numbers of T reg cells are found in gut-associated lymphoid tissue (GALT) [115] . It is likely that commensal microorganisms in the intestinal tract play an important role in the suppressive activity of T reg cells, as evidenced by the amelioration of infl ammatory bowel disease by probiotic bacteria-mediated T reg induction [116] . In addition, T reg cells induced by intestinal helminth infection suppressed airway allergy in ova-sensitized mice [117] . Thus, induction of T reg cells in the GALT suppresses not only the local infl ammation in the gut but also airway allergy. The effect of intestinal colonization or infection of mice with probiotic, parasitic, or pathogenic microorganisms on infl ammatory responses to fungal exposure in the lungs remains unknown. exhibited decreased airway hyperreactivity and decreased infl ux of neutrophils, but not eosinophils [104, 105] . Therefore, though PAR, Dectin-1, and TLRs 2 and 4 are involved in immune responses to fungi, only PAR-mediated effects have been demonstrated to promote allergic Th2 responses.
In addition to the variable immune responses to fungal molecular patterns, viable fungal particles also elicit contrasting responses when compared to nonviable or dormant particles. Large numbers of resting fungal spores introduced into the lungs of mice are phagocytosed by alveolar macrophages and result in little infl ammation [1] . Swollen or germinating spores may be more immunologically reactive, as they rapidly release allergens during germination [50] . Therefore, although resting spores may become airborne in fungicontaminated indoor environments, germinating spores may pose a greater threat to exposed individuals. Furthermore, common airborne fungal structures such as hyphae and subcellular fragments [2] may release greater quantities of fungal allergen than individual spores [13] . However, these particles are not effi ciently removed by phagocytosis [106] . Exposure to fragments may require greater interactions with other infl ammatory cells and thus exert greater infl uence on adaptive immune responses. Liquid suspensions containing A. fumigatus hyphae elicited Th2 responses in the draining lymph nodes of mice that received an intratracheal inoculation of fungi, compared to the Th1 responses induced by resting conidia [27] . Thus, while resting spores are taken up rapidly by alveolar macrophages and cause little or no infl ammation in the lungs of exposed individuals, germinating spores and/or hyphae may play a larger role in allergic airway responses due to higher expression of allergens or other recognized fungal structures that skew airway immune responses toward an allergic Th2 phenotype.
Host-susceptibility
Although the association between fungal exposure and allergy/asthma is widely accepted, the mechanism by which fungi induce allergy in some individuals but not in others remains less clear. Genetic susceptibility is an important component, although specifi c conditions of the environment during immune development are also critical [28] . Over the last two decades, the most popular explanation for increased allergic sensitization by environmental factors during development has been the 'hygiene hypothesis' [29, 107] . The hygiene hypothesis suggests that infections and non-invasive microbial exposures confer protection from allergic disease. Subsequent epidemiological studies have provided a wealth of supporting evidence. Numerous
Conclusion
Our understanding of the adverse health effects associated with fungal exposures in the home, workplace, or outdoors has been greatly enhanced through the use of animal models. Animal studies have examined acute and chronic exposures to spores and extracts, and have identifi ed early lung infl ammation and long term allergic airway responses. Although A. fumigatus serves as one model organism for fungal exposure, allergy, and infection, the potential for adverse respiratory effects to other species, including other common fungal conidia and fragments requires more detailed investigation. Future exposure assessment studies will likely identify other clinically important fungal species in indoor and outdoor environments. Small animal models will be required to confi rm their relevance. Continued genome sequencing of medically important species will provide powerful tools for understanding the importance of fungal genetics in allergy, asthma, and infection using small animal models. Animal studies have aided in the characterization of the receptors involved in the immune recognition of fungi such as TLRs 2 and 4, and Dectin-1. These studies have characterized the role of multiple cytokines and chemokines in lung infl ammation and allergy associated with fungal exposure. Future studies will be required to determine the mechanisms by which fungal allergens drive allergic airway responses, and the important genetic and environmental properties of both fungi and individuals exposed to fungi that increase the risk for allergic sensitization and disease.
